Cargando…
Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
Autores principales: | Angeletti, Andrea, Magnasco, Alberto, AntonellaTrivelli, Degl’Innocenti, Ludovica M., Piaggio, Giorgio, Lugani, Francesca, Caridi, Gianluca, Verrina, Enrico, Cravedi, Paolo, Ghiggeri, Gian Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720665/ https://www.ncbi.nlm.nih.gov/pubmed/35005321 http://dx.doi.org/10.1016/j.ekir.2021.10.018 |
Ejemplares similares
-
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Binding Truths: Seronegative Anti-Glomerular Basement Membrane Disease Mediated by IgM Anti-Glomerular Basement Membrane Antibodies
por: Antonelou, Marilina, et al.
Publicado: (2023) -
Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib
por: Latcha, Sheron, et al.
Publicado: (2018) -
An Unusual Case of Lysosomal Paraprotein Accumulation in Glomerular Endothelial Cells
por: Taneda, Sekiko, et al.
Publicado: (2019) -
Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
por: Nithagon, Pravarut, et al.
Publicado: (2021)